Currently, the progression of HCC may be facilitated by various CD8+ T cells populations, such as those targeting HBV core or polymerase antigens, as well as HBV non-specific CD8+ T cells, effector CD8+ T cells, and exhausted CD8+ T cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.